Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

Phase 1b is a bridging study for Kevetrin. Healthy volunteers where much of the data simply aims to show that oral K processes the same as injected K. It’s a short study much like the on for Prurisol that showed it to be abacavir. The Phase 2b will be a true optimization trial.